HOME >> BIOLOGY >> NEWS
JCI table of contents: October 1, 2002

Please find below two highlighted articles and the full table of contents for the October 1 issue.

**************************************************

NOT ALL MAMMALS VOMIT -- OR HOW TO STUDY EMESIS IN MICE

If biologists have learned anything over the past decade, it is how similar all mammals are at the genetic level. Greater than 90% of the genes found in mice are also found in humans, and we even share a significant amount of genes and genetic circuitries with creatures as different as fruit flies or puffer fish. This might not come as much of a surprise to physiologists who have long used animals to learn about basic mechanisms in organ function that are shared across vertebrates or mammals, but the extent of overlap is still impressive to most.

In many areas of biomedical research, rats or mice are the animal model of choice. And while most researchers are aware that mice are not just furry little humans that walk on all fours, some fundamental differences surprise even the experts. Among 10 scientists who identify themselves as mouse geneticists, only one was aware that mice (and in fact all rodents) lack a very fundamental behavior: they do not vomit.

While that in itself raises all sorts of interesting questions (for example about the evolution of vomiting, and its advantages and disadvantages for the survival of a species), it poses a very specific problem when one tries to use rodents to study a drug with side effects that include nausea and emesis (the medical term for vomiting).

Annette Robichaud and colleagues at the Merck Frosst Centre for Therapeutic Research in Montreal, Quebec, have faced this problem while developing drugs that inhibit a class of enzymes called class 4 phosphodiesterases, or PDE4s. PDE4 inhibitors have promise for the treatment of airway inflammatory diseases such as asthma, but their therapeutic potential has been limited by side effects of nausea and emesis. These side effec
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
2-Oct-2002


Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
3. JCI table of contents September 15, 2004
4. JCI table of contents: 1 September, 2004
5. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
6. JCI table of contents, 16 August, 2004
7. JCI table of contents, 2 August, 2004
8. When male fish hum, females swim in, thanks to hormones, adaptable hearing
9. JCI table of contents, 1 July 2004
10. Search and destroy protein turns tables on HIV
11. JCI table of contents, 15 June 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... ... of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announced it ... “Ready-to-Print” (RTP) cellular product formats (patent number AU 2015259373). This new patent ...
(Date:9/25/2019)... ... 25, 2019 , ... The esteemed dental implant specialists at ... for a variety of procedures, including single tooth replacement, new “teeth-in-a-day” immediately functioning ... implants offer patients permanent tooth replacement solutions that look and function very ...
(Date:9/25/2019)... ... September 25, 2019 , ... ... collaboration and dialogue, today announces its inaugural South CEO conference to ... Louisiana. , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has added ... 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. Ian ... Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the Chief ...
(Date:10/8/2019)... ... 2019 , ... Erchonia Corporation, the global leader in the ... the U.S. Food and Drug Administration (FDA) has granted the company 510(k) market ... chronic neck and shoulder pain of musculoskeletal origin. , Erchonia continues to be ...
(Date:10/3/2019)... ... 2019 , ... Cheyenne is a beautiful and strong Quarter Horse and a ... Rebel’s Run , which offers riding lessons and trail riding in Afton, Virginia. ... Mimi describes her as her “go to horse.” Thus, you can imagine ...
(Date:10/3/2019)... Va. (PRWEB) , ... October 02, 2019 , ... eKare’s ... prestigious NHS Digital Health Accelerator run by the East Midlands Academic Health Science Network ... the adoption of technology in NHS by providing support to develop and deploy solutions ...
Breaking Biology Technology:
Cached News: